These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23556453)

  • 1. Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.
    Hajj A; Khabbaz L; Laplanche JL; Peoc'h K
    Pharmacogenomics; 2013 Apr; 14(5):575-85. PubMed ID: 23556453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of opioid pharmacogenetics.
    Argoff CE
    Clin J Pain; 2010 Jan; 26 Suppl 10():S16-20. PubMed ID: 20026961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of opioids.
    Somogyi AA; Barratt DT; Coller JK
    Clin Pharmacol Ther; 2007 Mar; 81(3):429-44. PubMed ID: 17339873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
    Owusu Obeng A; Hamadeh I; Smith M
    Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
    Kreek MJ; Bart G; Lilly C; LaForge KS; Nielsen DA
    Pharmacol Rev; 2005 Mar; 57(1):1-26. PubMed ID: 15734726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic variation-- important for the clinical effect of opioids?].
    Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic polymorphisms and opioid therapies].
    Landau R
    Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
    Ruano G; Kost JA
    Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid genetics: the key to personalized pain control?
    Branford R; Droney J; Ross JR
    Clin Genet; 2012 Oct; 82(4):301-10. PubMed ID: 22780883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
    Freye E; Latasch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics of methadone maintenance treatment.
    Somogyi AA; Barratt DT; Ali RL; Coller JK
    Pharmacogenomics; 2014 May; 15(7):1007-27. PubMed ID: 24956254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone treatment for pain states.
    Toombs JD; Kral LA
    Am Fam Physician; 2005 Apr; 71(7):1353-8. PubMed ID: 15832538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attacking pain at its source: new perspectives on opioids.
    Stein C; Schäfer M; Machelska H
    Nat Med; 2003 Aug; 9(8):1003-8. PubMed ID: 12894165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid pharmacokinetic drug-drug interactions.
    Overholser BR; Foster DR
    Am J Manag Care; 2011 Sep; 17 Suppl 11():S276-87. PubMed ID: 21999760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic polymorphisms and human sensitivity to pain and opioids].
    Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K
    Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
    Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility and application of urine drug testing in chronic pain management with opioids.
    Nafziger AN; Bertino JS
    Clin J Pain; 2009 Jan; 25(1):73-9. PubMed ID: 19158549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.
    Lötsch J; Skarke C; Liefhold J; Geisslinger G
    Clin Pharmacokinet; 2004; 43(14):983-1013. PubMed ID: 15530129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.